Quest Diagnostics Incorporated: updates and filings

DGXNYSEHealthcare · Services-Medical Laboratories

Price

$258.86

November 19, 2026Market cap $28.4B

What Ploutos Investor adds for Quest Diagnostics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 63 daysAround Jan 21, 2027 · for Q4 2026

last Oct 22, 2026next Jan 21, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 26, 2026 latest annualOct 23, 2026 latest quarterly
  • Nov 10, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 23, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 22, 2026Other material events
    Form8-K
  • Oct 22, 2026Results of operations
    Form8-K
  • Oct 6, 2026Officer or director change
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 23, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 23, 2026Results of operations
    Form8-K
  • Jun 18, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 21, 2026Shareholder vote
    Form8-K
  • May 8, 2026Material agreement entered
    Form8-K
  • May 1, 2026Other material events
    Form8-K
  • Apr 30, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 22, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 21, 2026Results of operations
    Form8-K
  • Apr 6, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 6, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 12, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Feb 26, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 10, 2026Results of operations, other material events
    Form8-K
  • Jan 12, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Oct 21, 2025Results of operations
    Form8-K
  • Oct 21, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 23, 1996. Of its note and share prospectuses (424B, FWP), the newest 40 of 46.

The full analysis

What do Quest Diagnostics's filings show?

The filings are where every one of Quest Diagnostics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.